albendazole 200 MG Oral Tablet [Albenza]

RxCUI: 211148
RxNorm name: albendazole 200 MG Oral Tablet [Albenza]
Display name: albendazole 200 MG Oral Tablet [Albenza]
Full name: albendazole 200 MG Oral Tablet [Albenza]
Term type: SBD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:48

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ALBENZA	ALBENDAZOLE	Amneal Pharmaceuticals LLC	1977a867-0ee1-44c0-8da3-fe59c48699f5	2019-09-23	Warnings, Adverse reactions	Exact identifier rxcui: 211148

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
1977a867-0ee1-44c0-8da3-fe59c48699f5	Albenza 200 MG Oral Tablet [PSN] · albendazole 200 MG Oral Tablet [Albenza] [SBD] · Albenza 200 MG Oral Tablet [SY]	3	14	These highlights do not include all the information needed to use ALBENZA ® safely and effectively. See full prescribing information for ALBENZA. ALBENZA ® (albendazole) tablets, for oral use Initial U.S. Approval: 1996	20190923
62a3f663-9e76-47f6-b089-54e4db01f697	Albenza 200 MG Oral Tablet [PSN] · albendazole 200 MG Oral Tablet [Albenza] [SBD] · Albenza 200 MG Oral Tablet [SY]	3	1	These highlights do not include all the information needed to use ALBENZA ® safely and effectively. See full prescribing information for ALBENZA. ALBENZA ® (albendazole) tablets, for oral use ALBENZA ® (albendazole) chewable tablets, for oral use Initial U.S. Approval: 1996	20170908